{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:59:40Z","timestamp":1790715580142,"version":"4.1.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fabry disease (FD) is a rare X-linked lysosomal storage disorder and also a rare cause of coronary stenosis. We present a case of coronary stenosis in a 39-year-old man with FD, including optical coherence tomography (OCT) imaging findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>A 39-year-old man was admitted with unstable angina. He had been previously diagnosed with FD through \u03b1-galactosidase A enzyme activity testing and genetic analysis. Coronary angiography (CAG) revealed 90% stenosis in the proximal left anterior descending artery (pLAD). The pre-procedural CAG-based fractional flow reserve (caFFR) was 0.57, and the CAG-based index of microcirculatory resistance (caIMR) was 14.4. Drug-coated balloon angioplasty was performed, achieving post-procedural stenosis of 0%, with caFFR improving to 0.86 and caIMR decreasing to 9.4. He had no traditional atherosclerotic cardiovascular disease risk factors. Although CAG indicated 90% stenosis of the pLAD, OCT imaging did not demonstrate typical atherosclerotic or fibrocalcific plaques. However, based on the patient\u2019s clinical features, OCT findings, and previous literature, we could not definitively determine the specific aetiology of the coronary stenosis (FD, coronary atherosclerosis, or both). During a 2-year follow-up, he remained angina-free.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Although OCT may aid in differentiating FD-related coronary involvement due to its high resolution and ability to detect FD-compatible changes, it cannot reliably determine whether the fibrous plaque morphology and loss of layered architecture are attributable to FD-related coronary pathology or premature atherosclerosis, representing a fundamental imaging limitation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytag652","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T11:22:15Z","timestamp":1788693735000},"source":"Crossref","is-referenced-by-count":0,"title":["Coronary stenosis in Fabry disease with optical coherence tomography imaging presentation: a case report"],"prefix":"10.1093","volume":"10","author":[{"given":"Zesheng","family":"Peng","sequence":"first","affiliation":[{"name":"Department of Cardiology, Peking University First Hospital , No.8 Xishiku Street, Beijing 100034 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4562-3183","authenticated-orcid":false,"given":"Bo","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Peking University First Hospital , No.8 Xishiku Street, Beijing 100034 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-3329","authenticated-orcid":false,"given":"Yawen","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University First Hospital , No.8 Xishiku Street, Beijing 100034 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6241-4207","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University First Hospital , No.8 Xishiku Street, Beijing 100034 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1305-3980","authenticated-orcid":false,"given":"Wei","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Peking University First Hospital , No.8 Xishiku Street, Beijing 100034 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"2026092916015974200_ytag652-B1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000060184","article-title":"Fabry disease (alpha-galactosidase A deficiency): renal involvement and enzyme replacement therapy","volume":"136","author":"Desnick","year":"2001","journal-title":"Contrib Nephrol"},{"key":"2026092916015974200_ytag652-B2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"2026092916015974200_ytag652-B3","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jcmg.2018.03.020","article-title":"Proposed stages of myocardial phenotype development in Fabry disease","volume":"12","author":"Nordin","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026092916015974200_ytag652-B4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijcard.2022.07.046","article-title":"Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease","volume":"369","author":"Graziani","year":"2022","journal-title":"Int J Cardiol"},{"key":"2026092916015974200_ytag652-B5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/hrt.2004.054015","article-title":"Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A","volume":"92","author":"Elliott","year":"2006","journal-title":"Heart"},{"key":"2026092916015974200_ytag652-B6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1253\/circj.CJ-18-0734","article-title":"Unexpectedly high prevalence of coronary spastic angina in patients with Anderson-Fabry disease","volume":"83","author":"Kitani","year":"2019","journal-title":"Circ J"},{"key":"2026092916015974200_ytag652-B7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00428-005-0089-x","article-title":"Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement","volume":"448","author":"Schiffmann","year":"2006","journal-title":"Virchows Arch"},{"key":"2026092916015974200_ytag652-B8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ahj.2020.04.006","article-title":"Predictors of Fabry disease in patients with hypertrophic cardiomyopathy: how to guide the diagnostic strategy?","volume":"226","author":"Azevedo","year":"2020","journal-title":"Am Heart J"},{"key":"2026092916015974200_ytag652-B9","doi-asserted-by":"crossref","first-page":"10088","DOI":"10.3390\/ijms221810088","article-title":"Pathogenesis and molecular mechanisms of Anderson-Fabry disease and possible new molecular addressed therapeutic strategies","volume":"22","author":"Tuttolomondo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026092916015974200_ytag652-B10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/ATVBAHA.113.302200","article-title":"Globotriaosylceramide induces lysosomal degradation of endothelial KCa3.1 in Fabry disease","volume":"34","author":"Choi","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026092916015974200_ytag652-B11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jacc.2010.11.018","article-title":"Cardiovascular events in patients with Fabry disease natural history data from the Fabry registry","volume":"57","author":"Patel","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026092916015974200_ytag652-B12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.carpath.2009.05.003","article-title":"A detailed pathologic examination of heart tissue from three older patients with Anderson-Fabry disease on enzyme replacement therapy","volume":"19","author":"Sheppard","year":"2010","journal-title":"Cardiovasc Pathol"},{"key":"2026092916015974200_ytag652-B13","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJM198406143102415","article-title":"Case 2-1984: Fabry\u2019s disease","volume":"310","year":"1984","journal-title":"N Engl J Med"},{"key":"2026092916015974200_ytag652-B14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1012428009627","article-title":"Cardiac manifestations in Fabry disease","volume":"24","author":"Linhart","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"2026092916015974200_ytag652-B15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41569-022-00687-9","article-title":"Optical coherence tomography in coronary atherosclerosis assessment and intervention","volume":"19","author":"Araki","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2026092916015974200_ytag652-B16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.26599\/1671-5411.2024.02.001","article-title":"Chinese expert consensus on the clinical application of drug-coated balloon (2nd Edition)","volume":"21","author":"Ge","year":"2024","journal-title":"J Geriatr Cardiol"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytag652\/70989494\/ytag652.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/9\/ytag652\/70989494\/ytag652.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/9\/ytag652\/70989494\/ytag652.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:02:15Z","timestamp":1790712135000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytag652\/8787792"}},"subtitle":[],"editor":[{"given":"Dzan","family":"Horozic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Jamol","family":"Uzokov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Constantin","family":"K\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Deepti","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,8,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytag652","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,27]]},"article-number":"ytag652"}}